Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …

Saponins are steroidal or triterpenoid glycoside that is distinguished by the soap-forming
nature. Different saponins have been characterized and purified and are gaining attention in …

Purpose The phase III PROCLAIM study evaluated overall survival (OS) of concurrent
pemetrexed-cisplatin and thoracic radiation therapy (TRT) followed by consolidation …

Background The optimal chemotherapy regimen administered currently with radiation in
patients with stage III non-small cell lung cancer (NSCLC) remains unclear. A multicenter …

Importance Consolidative programmed death ligand-1 (PD-L) inhibition after
chemoradiotherapy improves overall survival and progression-free survival (PFS) for stage …

PURPOSE This trial aimed to assess the efficacy and safety of the paclitaxel plus fluorouracil
regimen versus the cisplatin plus fluorouracil regimen in definitive concurrent …

Stage III non-small cell lung cancer (NSCLC) includes a highly heterogeneous group of
patients with differences in the extent and localization of disease. Many aspects of stage III …

ABSTRACT Introduction: Nearly 50,000 incident cancer cases are reported in Veterans
Affairs (VA) Central Cancer Registry (VACCR) annually. This article provides an updated …

Purpose: Cisplatin is increasingly used in chemoimmunotherapy and may enhance the T
cell–dependent radiation-induced abscopal effect, but how it promotes antitumor immunity is …

Background Concurrent chemoradiotherapy is an established component of the
nonoperative management of locally advanced head and neck squamous cell carcinoma …